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renal  failure  and  diffuse  thrombosis  who  was 
successfully treated with intermittent intravenous 
bolus  administration  of  recombinant  hirudin 
(lepirudin) for a long time (forty days).




were  both  normal.  CT-scan  of  the  abdomen 
revealed a mass (diameters 3.2x4.2x2.1cm) on the 
upper pole of the left kidney. Renal angiography 
showed  normal  patency  of  both  renal  arteries. 
Surgical resection of the renal mass was performed. 
Histopathological  examination  was  consistent 



































(normal  range  3.5-14),  creatinine  371.3μmol/l 
(normal  range  44.3-105),  lactate  dehydrogenase 
(LDH)  750  iu/l  (normal  range  <  190),  creatine 
phosphokinase (CPK) 810 iu/l (normal range < 100). ©  The Ulster Medical Society, 2006.
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The rest of the biochemical work-up was normal. 
Doppler  examination  of  renal  arteries  revealed 
total  absence  of  blood  flow  bilaterally.  Because 
of the recent exposure to unfractionated heparin 
during angiography, there was a strong suspicion 
of  HITT  syndrome,  which  was  confirmed,  with 
the identification of antibodies against complexes 


















of  the  next  dialysis.  Each  hemodialysis  session 
was completed successfully, clot formation in the 
extracorporeal circuit was prevented and no bleeding 

















Heparin-induced  thrombocytopenia  (HIT)  is  an 
immune-mediated  clinicopathological  syndrome 
where  the  diagnosis  should  be  based  on  the 





microparticles  which  in  turn  promote  thrombin 




































exists  concerning  the  use  of  lepirudin  in  renal 
failure.5-8 To our knowledge, the longest application 
of  lepirudin  in  a  haemodialysis  patient  covered 
more than 50 haemodialysis sessions in one single 
patient.9 There is currently no ideal haemodialysis 
anticoagulation  agent  for  a  patient  with  HIT, 
although Argatroban could have some theoretical 
advantages.  Other  procedures  and  agents  which ©  The Ulster Medical Society, 2006.




prostacyclin  analogues,  thrombolytic  therapy  as 
well as thromboembolectomy) could not be used 
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